GPR37 modulates body weight and insulin sensitivity in a sex-biased manner
PLOS One · 28.05.2026 · 21 (5) · e0349406
DOI: 10.1371/journal.pone.0349406 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 28.05.2026. Verfasst von Mariam Ahmed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Program, Smith College, Northampton, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Insulin Resistance, Body Weight. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association-American Stroke Association, American Heart Association.
Abstract (Originalsprache)
Metabolic disorders are a growing public health concern in the United States, with approximately 40% of the population living with obesity. The urgent need for novel therapeutic targets has driven interest in G protein–coupled receptors (GPCRs), a diverse group of seven-transmembrane receptors that regulate various physiological processes and represent a significant portion of current drug targets. In this study, we investigated the role of GPR37, a brain-enriched orphan GPCR, in systemic glucose regulation. Using heterozygous Gpr37 + /- mice, we assessed body weight, glucose tolerance, and insulin sensitivity. Male Gpr37 + /- mice exhibited significantly reduced body weight, an enhanced metabolic response to fasting, and increased insulin sensitivity compared to wild-type controls. These findings indicate that reduced Gpr37 gene dosage is associated with metabolic efficiency, particularly in the regulation of glucose metabolism, and reveal a previously unrecognized sex-biased role for GPR37 in systemic energy homeostasis. Taken together, these data suggest that GPR37 contributes to metabolic regulation and represents a candidate pathway for further pharmacological and tissue-specific study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuroscience Program, Smith College, Northampton, Massachusetts, United States of America.
- Department of Pharmacology and Toxicology, Morehouse School of Medicine, Atlanta, Georgia, United States of America.
ORCID-Profile: Sharon Owino
Förderung
- American Heart Association-American Stroke Association
- American Heart Association
Zitieren
APA
Ahmed, M., Santos, M. N., Abdelsayed, K., Liu, C., Xuseen, N., Boakye, P. A., & Owino, S. (2026). GPR37 modulates body weight and insulin sensitivity in a sex-biased manner. PLOS One, 21(5), e0349406. https://doi.org/10.1371/journal.pone.0349406
Vancouver
Ahmed M, Santos MN, Abdelsayed K, Liu C, Xuseen N, Boakye PA, et al. GPR37 modulates body weight and insulin sensitivity in a sex-biased manner. PLOS One. 2026;21(5):e0349406. doi:10.1371/journal.pone.0349406
BibTeX
@article{Ahmed2026,
author = {Ahmed, Mariam and Santos, Mariela Nunez and Abdelsayed, Karen and Liu, Corrine and Xuseen, Nimco and Boakye, Pokuaa Adwoa and Owino, Sharon},
title = {GPR37 modulates body weight and insulin sensitivity in a sex-biased manner},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0349406},
doi = {10.1371/journal.pone.0349406}
}
EUVIMED